| Authors: |
Chen GL; Department of Medicine, BMT Program, Roswell Park Cancer Institute, Buffalo, New York., Liu H; Department of Medicine, BMT Program, Roswell Park Cancer Institute, Buffalo, New York., Zhang Y; Department of Medicine, BMT Program, Roswell Park Cancer Institute, Buffalo, New York., Thomas J; Department of Medicine, BMT Program, Roswell Park Cancer Institute, Buffalo, New York., Ross M; Department of Medicine, BMT Program, Roswell Park Cancer Institute, Buffalo, New York., Wang ES; Department of Medicine, Leukemia Division, Roswell Park Cancer Institute, Buffalo, New York., Block AW; Clinical Cytogenetics Laboratory, Roswell Park Cancer Institute, Buffalo, New York., Sait S; Clinical Cytogenetics Laboratory, Roswell Park Cancer Institute, Buffalo, New York., Deeb G; Department of Pathology, Roswell Park Cancer Institute, Buffalo, New York., Wallace P; Department of Flow Cytometry, Roswell Park Cancer Institute, Buffalo, New York., Wetzler M; Department of Medicine, Leukemia Division, Roswell Park Cancer Institute, Buffalo, New York., Hahn T; Department of Medicine, BMT Program, Roswell Park Cancer Institute, Buffalo, New York., McCarthy PL; Department of Medicine, BMT Program, Roswell Park Cancer Institute, Buffalo, New York. Electronic address: philip.mccarthy@RoswellPark.org. |